GW&K Investment Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-183,885
Closed -$3.65M – 924
2023
Q1
$3.65M Buy
183,885
+358
+0.2% +$6.18K 0.04% 284
2022
Q4
$2.5M Sell
183,527
-4,673
-2% -$65.1K 0.03% 300
2022
Q3
$2.61M Sell
188,200
-2,517
-1% -$37.4K 0.03% 291
2022
Q2
$2.74M Sell
190,717
-1,039
-0.5% -$18K 0.03% 286
2022
Q1
$4.33M Sell
191,756
-1,315
-0.7% -$25.5K 0.04% 265
2021
Q4
$3.63M Sell
193,071
-9,815
-5% -$262K 0.03% 289
2021
Q3
$6.66M Sell
202,886
-3,120
-2% -$116K 0.06% 239
2021
Q2
$8.79M Sell
206,006
-4,040
-2% -$158K 0.08% 228
2021
Q1
$8.05M Buy
210,046
+34,379
+20% +$1.46M 0.07% 225
2020
Q4
$7.69M Sell
175,667
-2,682
-2% -$101K 0.08% 233
2020
Q3
$7.02M Sell
178,349
-3,291
-2% -$106K 0.09% 227
2020
Q2
$5.73M Sell
181,640
-64,514
-26% -$2.41M 0.08% 228
2020
Q1
$8.67M Sell
246,154
-14,812
-6% -$624K 0.15% 194
2019
Q4
$12.7M Sell
260,966
-10,799
-4% -$492K 0.17% 196
2019
Q3
$12.9M Buy
271,765
+78,644
+41% +$3.7M 0.18% 191
2019
Q2
$8.29M Sell
193,121
-2,560
-1% -$99.4K 0.13% 213
2019
Q1
$7.57M Sell
195,681
-31,114
-14% -$1.05M 0.12% 211
2018
Q4
$6.46M Sell
226,795
-12,575
-5% -$399K 0.13% 195
2018
Q3
$9.37M Sell
239,370
-5,971
-2% -$221K 0.15% 191
2018
Q2
$7.93M Buy
245,341
+108,581
+79% +$2.99M 0.13% 198
2018
Q1
$3M Buy
136,760
+862
+0.6% +$20.7K 0.05% 222
2017
Q4
$3.22M Buy
135,898
+40,133
+42% +$1.01M 0.06% 214
2017
Q3
$2.7M Buy
+95,765
New +$2.91M 0.04% 207

Other funds holding CSII

GW&K Investment Management's CSII Position: Q2 2023 in Review

GW&K Investment Management sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 183,885 shares — an estimated $3.65M sold.

GW&K Investment Management first reported a position in CSII in Q3 2017 and held it in 23 quarters. The position peaked at $12.9M in Q3 2019. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

  • GW&K Investment Management reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
  • GW&K Investment Management sold 183,885 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $3.65M.
  • GW&K Investment Management first reported a position in Cardiovascular Systems, Inc. in Q3 2017 and held it in 23 quarters.
  • GW&K Investment Management's Cardiovascular Systems, Inc. position peaked at $12.9M in Q3 2019.
  • 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on GW&K Investment Management's 13F filing for Q2 2023, filed 9 Aug 2023.